Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.59M | 39.52M | 33.36M | 26.46M | 22.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.59M | 39.52M | 33.36M | 26.46M | 22.16M |
| Cost of Revenue | 12.48M | 11.08M | 9.26M | 5.09M | 4.19M |
| Gross Profit | 35.12M | 28.43M | 24.10M | 21.38M | 17.97M |
| SG&A Expenses | 18.36M | 15.59M | 12.24M | 8.68M | 5.77M |
| Depreciation & Amortization | 7.07M | 5.55M | 4.02M | 2.78M | 1.12M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.92M | 32.25M | 25.52M | 16.58M | 11.12M |
| Operating Income | 9.67M | 7.27M | 7.85M | 9.88M | 11.04M |
| Income Before Tax | 5.76M | 1.87M | 2.96M | 9.49M | 12.29M |
| Income Tax Expenses | -6.38M | -7.37M | -8.59M | -6.37M | -10.32M |
| Earnings from Continuing Operations | 12.14 | 9.25 | 11.55 | 15.86 | 22.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.14M | 9.25M | 11.55M | 15.86M | 22.60M |
| EBIT | 9.67M | 7.27M | 7.85M | 9.88M | 11.04M |
| EBITDA | 16.56M | 12.64M | 11.69M | 12.57M | 12.07M |
| EPS Basic | 0.47 | 0.37 | 0.47 | 0.66 | 0.92 |
| Normalized Basic EPS | 0.20 | 0.12 | 0.15 | 0.29 | 0.32 |
| EPS Diluted | 0.46 | 0.36 | 0.46 | 0.63 | 0.89 |
| Normalized Diluted EPS | 0.20 | 0.12 | 0.14 | 0.29 | 0.32 |
| Average Basic Shares Outstanding | 102.38M | 100.62M | 99.00M | 97.54M | 97.67M |
| Average Diluted Shares Outstanding | 104.13M | 102.19M | 100.38M | 99.44M | 99.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |